INSERM (2024). The consumption of certain food additive emulsifiers may increase the risk of cancer. https://presse.inserm.fr/en/la-consommation-de-certains-additifs-alimentaires-emulsifiants-serait-associee-a-un-risque-accru-de-cancers/68077/EFSA (2018). Re‐evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives.
EFSA Journal, 16(4), e05238. https://doi.org/10.2903/j.efsa.2018.5238
IARC (2018). Agents Classified by the IARC Monographs, Volumes 1–123 https://monographs.iarc.fr/wp-content/uploads/2018/09/ClassificationsAlphaOrder.pdf
WHO (2014). Evaluation of certain food additives - Seventy-ninth report of the Joint FAO/WHO Expert Committee on Food Additives. https://iris.who.int/bitstream/handle/10665/150883/9789241209908_eng.pdf?sequence=1#page=26
FDA (1973). Substances Added to Food (formerly EAFUS) - CARRAGEENAN. https://www.hfpappexternal.fda.gov/scripts/fdcc/index.cfm?set=FoodSubstances&id=CARRAGEENAN&sort=Sortterm_ID&order=ASC&startrow=1&type=basic&search=carrageenan
Kimilu N, Gładyś-Cieszyńska K, Pieszko M, Mańkowska-Wierzbicka D, Folwarski M (2024). Carrageenan in the Diet: Friend or Foe for Inflammatory Bowel Disease? Nutrients. 2024 Jun 6;16(11):1780. doi: 10.3390/nu16111780. PMID: 38892712; PMCID: PMC11174395. https://pubmed.ncbi.nlm.nih.gov/38892712/
Gao Y, Wu A, Li Y, Chang Y, Xue C, Tang Q (2022). The risk of carrageenan-induced colitis is exacerbated under high-sucrose/high-salt diet. Int J Biol Macromol. 2022 Jun 15;210:475-482. doi: 10.1016/j.ijbiomac.2022.04.158. Epub 2022 Apr 26. PMID: 35483512. https://pubmed.ncbi.nlm.nih.gov/35483512/
Naimi, S., Viennois, E., Gewirtz, A.T. et al (2021). Direct impact of commonly used dietary emulsifiers on human gut microbiota. Microbiome 9, 66 (2021). https://doi.org/10.1186/s40168-020-00996-6
Mi Y, Chin YX, Cao WX, Chang YG, Lim PE, Xue CH, Tang QJ (2020). Native κ-carrageenan induced-colitis is related to host intestinal microecology. Int J Biol Macromol. 2020 Mar 15;147:284-294. doi: 10.1016/j.ijbiomac.2020.01.072. Epub 2020 Jan 8. PMID: 31926226. https://pubmed.ncbi.nlm.nih.gov/31926226/
Prasedya ES, Miyake M, Kobayashi D, Hazama A (2016). Carrageenan delays cell cycle progression in human cancer cells in vitro demonstrated by FUCCI imaging. BMC Complement Altern Med. 2016 Aug 4;16:270. https://pubmed.ncbi.nlm.nih.gov/27487950/
The Cornucopia Institute (2016). Carrageenan - New Studies Reinforce Link to Inflammation, Cancer and Diabetes. https://www.cornucopia.org/wp-content/uploads/2016/04/CarageenanReport-2016.pdf
Bhattacharyya S, O-Sullivan I, Katyal S, Unterman T, Tobacman JK (2012). Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice. Diabetologia. 2012 Jan;55(1):194-203. https://pubmed.ncbi.nlm.nih.gov/22011715/
Benard, Claudine et al (2010). “Degraded carrageenan causing colitis in rats induces TNF secretion and ICAM-1 upregulation in monocytes through NF-kappaB activation” PloS one vol. 5,1 e8666. 13 Jan. 2010. https://pmc.ncbi.nlm.nih.gov/articles/PMC2800179/
Tobacman, J K (2001). “Review of harmful gastrointestinal effects of carrageenan in animal experiments” Environmental health perspectives vol. 109,10 ; 2001: 983-94. https://pmc.ncbi.nlm.nih.gov/articles/PMC1242073/
